1. Home
  2. RLAY vs NWTN Comparison

RLAY vs NWTN Comparison

Compare RLAY & NWTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • NWTN
  • Stock Information
  • Founded
  • RLAY 2015
  • NWTN 2016
  • Country
  • RLAY United States
  • NWTN United Arab Emirates
  • Employees
  • RLAY N/A
  • NWTN N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • NWTN Auto Manufacturing
  • Sector
  • RLAY Health Care
  • NWTN Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • NWTN Nasdaq
  • Market Cap
  • RLAY 576.1M
  • NWTN 546.4M
  • IPO Year
  • RLAY 2020
  • NWTN N/A
  • Fundamental
  • Price
  • RLAY $3.63
  • NWTN $1.58
  • Analyst Decision
  • RLAY Strong Buy
  • NWTN
  • Analyst Count
  • RLAY 11
  • NWTN 0
  • Target Price
  • RLAY $18.40
  • NWTN N/A
  • AVG Volume (30 Days)
  • RLAY 1.6M
  • NWTN 262.2K
  • Earning Date
  • RLAY 08-05-2025
  • NWTN 01-01-0001
  • Dividend Yield
  • RLAY N/A
  • NWTN N/A
  • EPS Growth
  • RLAY N/A
  • NWTN N/A
  • EPS
  • RLAY N/A
  • NWTN N/A
  • Revenue
  • RLAY $7,679,000.00
  • NWTN $11,995,000.00
  • Revenue This Year
  • RLAY $14.31
  • NWTN N/A
  • Revenue Next Year
  • RLAY N/A
  • NWTN N/A
  • P/E Ratio
  • RLAY N/A
  • NWTN N/A
  • Revenue Growth
  • RLAY N/A
  • NWTN N/A
  • 52 Week Low
  • RLAY $1.78
  • NWTN $0.30
  • 52 Week High
  • RLAY $10.72
  • NWTN $3.48
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 63.22
  • NWTN 47.58
  • Support Level
  • RLAY $3.10
  • NWTN $1.43
  • Resistance Level
  • RLAY $3.75
  • NWTN $2.22
  • Average True Range (ATR)
  • RLAY 0.23
  • NWTN 0.22
  • MACD
  • RLAY 0.03
  • NWTN -0.07
  • Stochastic Oscillator
  • RLAY 84.42
  • NWTN 22.01

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About NWTN NWTN Inc.

NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, it operates in The United States, The United Arab Emirates, Mainland China.

Share on Social Networks: